Skip to main content
Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
0.318
-0.013 (-3.89%)
At close: Apr 26, 2024, 4:00 PM
0.330
+0.012 (3.64%)
After-hours: Apr 26, 2024, 7:36 PM EDT

Telesis Bio Revenue

In the year 2023, Telesis Bio had annual revenue of $27.51M with 0.27% growth. Revenue in the quarter ending December 31, 2023 was $6.98M, a -26.32% decrease year-over-year.

Revenue (ttm)
$27.51M
Revenue Growth
+0.27%
P/S Ratio
0.35
Revenue / Employee
$200,796
Employees
137
Market Cap
9.58M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202327.51M74.00K0.27%
Dec 31, 202227.44M16.39M148.44%
Dec 31, 202111.04M4.47M67.93%
Dec 31, 20206.58M1.77M36.86%
Dec 31, 20194.81M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 57.31M
Novo Integrated Sciences 13.66M
Genetic Technologies 5.78M
Aeterna Zentaris 4.50M
BioCardia 477.00K
Revenue Rankings

TBIO News

More News